Vertex Pharmaceuticals
VRTX
#186
Rank
NZ$200.62 B
Marketcap
NZ$782.50
Share price
-1.13%
Change (1 day)
6.09%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: NZ$200.62 Billion

As of January 2026 Vertex Pharmaceuticals has a market cap of NZ$200.62 Billion. This makes Vertex Pharmaceuticals the world's 186th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$200.62 B-2.1%
2025NZ$204.92 B9.79%
2024NZ$186.65 B12.58%
2023NZ$165.79 B42%
2022NZ$116.75 B42.69%
2021NZ$81.82 B-3.94%
2020NZ$85.17 B1.16%
2019NZ$84.19 B33.57%
2018NZ$63.03 B18.13%
2017NZ$53.36 B102.3%
2016NZ$26.37 B-41.75%
2015NZ$45.28 B23.53%
2014NZ$36.65 B73.42%
2013NZ$21.13 B91%
2012NZ$11.06 B24.7%
2011NZ$8.87 B-3.96%
2010NZ$9.24 B-21.66%
2009NZ$11.79 B59.21%
2008NZ$7.40 B83.87%
2007NZ$4.02 B-39.85%
2006NZ$6.69 B53%
2005NZ$4.37 B265.96%
2004NZ$1.19 B-3.7%
2003NZ$1.24 B-46.28%
2002NZ$2.31 B-47.97%
2001NZ$4.44 B-53.79%
2000NZ$9.61 B459.13%
1999NZ$1.72 B20.16%
1998NZ$1.43 B-0.17%
1997NZ$1.43 B19.31%
1996NZ$1.20 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Vertex Pharmaceuticals was reported to be:

NZ$200.80 Billion
by Nasdaq info icon info icon
NZ$202.91 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
NZ$267.97 B 33.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$682.64 B 240.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$482.65 B 140.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$202.05 B 0.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$916.56 B 356.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
NZ$0.69 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA